securities fraud

Law firm sues Oracle for allegedly misleading investors about AI spending's near-term revenue potential. Stock fell 11% after earnings missed expectations.

Fermi Inc. faces securities fraud lawsuit over Project Matador disclosures, alleging misrepresentation of tenant commitments. Stock fell 33% after primary tenant withdrew funding in December 2025.

Ardent Health faces class action lawsuit over misrepresented revenue recognition practices. Company disclosed $43M revenue reduction and 33% stock decline following accounting restatement allegations.

BRBR faces securities fraud lawsuit alleging misrepresented sales growth. Investors must file claims by March 23, 2026.

Kyndryl faces securities lawsuit after SEC discovers accounting irregularities. Stock plunges 52% as CFO and General Counsel resign.

Plug Power faces securities fraud lawsuit for allegedly misleading investors about a $1.66 billion DOE hydrogen funding program. Stock fell over 27% after CEO departure and loan suspension.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and undisclosed data center project delays. Class action deadline: March 13, 2026.

Hub Group to restate 2025 financial results due to accounting errors in transportation costs and payables, causing 24% stock decline and triggering potential shareholder litigation.

Rosen Law Firm investigates NUAI following short seller allegations of questionable spending priorities and CEO's penny stock history. Stock fell 6.9%.

Rosen Law Firm investigates PennyMac Financial for alleged disclosure issues after Q4 earnings triggered 33% stock decline on January 30, 2026.

Trip.com faces securities investigation following Chinese antitrust probe. Stock dropped 17% after disclosure; investors may pursue class action lawsuit for alleged misleading disclosures.

Robbins Geller sues Richtech Robotics for misrepresenting Microsoft partnership scope. Stock fell 29% after Microsoft clarified relationship was limited to AI lab, not commercial deal.

Rosen Law Firm files securities class action against Inovio Pharmaceuticals for allegedly making false statements about manufacturing deficiencies and regulatory prospects between October 2023 and December 2025.

Class action lawsuit filed against China Liberal Education over alleged pump-and-dump scheme involving fake investment advisors on social media that artificially inflated stock prices.

Securities class action filed against Kyndryl for false disclosures. Investors who purchased stock August 2024-February 2026 can claim damages; lead plaintiff deadline April 13, 2026.

Law firm investigates Ramaco Resources for alleged securities fraud over inactive Wyoming mine despite reported groundbreaking. Class action deadline: March 31, 2026.

Pomdoctor investors must act by April 13, 2026, to join securities fraud class action alleging false statements and manipulated trading volumes that caused stock decline.

Rosen Law Firm investigates Nidec over accounting irregularities in China operations. Stock plunged 22.7% following disclosure of management-related accounting issues.

Law firm sues REGENXBIO for allegedly hiding safety concerns about gene therapy RGX-111. Stock dropped 17.8% after FDA clinical hold due to tumor in trial participant.

Rosen Law Firm sued uniQure for allegedly misleading investors about FDA approval timelines and regulatory study status between September-October 2025.